Royal Bank of Canada’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-212
| Closed | -$2K | – | 6615 |
|
2025
Q1 | $2K | Sell |
212
-117,144
| -100% | -$1.11M | ﹤0.01% | 6162 |
|
2024
Q4 | $872K | Buy |
+117,356
| New | +$872K | ﹤0.01% | 3254 |
|
2024
Q3 | – | Sell |
-590
| Closed | -$7K | – | 6360 |
|
2024
Q2 | $7K | Buy |
590
+268
| +83% | +$3.18K | ﹤0.01% | 6043 |
|
2024
Q1 | $7K | Buy |
322
+184
| +133% | +$4K | ﹤0.01% | 5864 |
|
2023
Q4 | $1K | Buy |
138
+136
| +6,800% | +$986 | ﹤0.01% | 6346 |
|
2023
Q3 | $0 | Sell |
2
-4
| -67% | – | ﹤0.01% | 6558 |
|
2023
Q2 | $1K | Buy |
6
+1
| +20% | +$167 | ﹤0.01% | 6497 |
|
2023
Q1 | $2K | Buy |
5
+3
| +150% | +$1.2K | ﹤0.01% | 6358 |
|
2022
Q4 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 6435 |
|
2022
Q3 | – | Sell |
-1
| Closed | -$2K | – | 6927 |
|
2022
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 6447 |
|
2022
Q1 | $3K | Sell |
1
-4
| -80% | -$12K | ﹤0.01% | 6885 |
|
2021
Q4 | $24K | Buy |
5
+3
| +150% | +$14.4K | ﹤0.01% | 6182 |
|
2021
Q3 | $15K | Buy |
2
+1
| +100% | +$7.5K | ﹤0.01% | 6283 |
|
2021
Q2 | $12K | Hold |
1
| – | – | ﹤0.01% | 6289 |
|
2021
Q1 | $13K | Hold |
1
| – | – | ﹤0.01% | 6167 |
|
2020
Q4 | $7K | Buy |
+1
| New | +$7K | ﹤0.01% | 5963 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 6096 |
|
2020
Q2 | – | Hold |
0
| – | -$1K | – | 6118 |
|
2020
Q1 | – | Sell |
-1
| Closed | -$9K | – | 5890 |
|
2019
Q4 | $9K | Buy |
+1
| New | +$9K | ﹤0.01% | 5567 |
|
2019
Q3 | – | Hold |
0
| – | -$1K | – | 5975 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 5707 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5794 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 6086 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 5906 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 5699 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 5762 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 5924 |
|